Table 3. Correlation between serum TIMP-1 levels and other baseline clinical and biochemical characteristics.
TIMP-1 (ng/mL) | |
APACHE-II score | rho = 0.33; P = 0.001 |
GCS score | rho = −0.22; P = 0.03 |
Lactic acid (mmol/L) | rho = 0.24; P = 0.02 |
TNF-alpha (pg/mL) | rho = 0.53; P<0.001 |
Tissue Factor (pg/mL) | rho = 0.43; P<0.001 |
PAI-1 (ng/mL) | rho = 0.06; P = 0.71 |
Platelets (cells/mm3) | rho = −0.05; P = 0.61 |
INR | rho = 0.10; P = 0.35 |
aPTT (seconds) | rho = 0.08; P = 0.49 |
Fibrinogen (mg/dL) | rho = 0.07; P = 0.59 |
MMP-9 (ng/mL) | rho = 0.02; P = 0.88 |
TIMP = tissue inhibitor of matrix metalloproteinase; GCS = Glasgow Coma Scale; TNF = tumor necrosis factor; PAI = plasminogen activator inhibitor; INR = international normalized ratio; aPTT = activated partial thromboplastin time; MMP = matrix metalloproteinase. Bonferroni correction to control the multiple testing problem (0.05/11 = 0.004) was used. Only P-values lower than 0.004 were considered statistically significant.